PTCT FY 2017 Earnings — PTC Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

PTCTPTC Therapeutics, Inc.

$5B

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$194M+135.0% YoY

Gross Profit

$190M97.6% margin

Operating Income

-$64M-33.1% margin

Net Income

-$79M-40.6% margin

EPS (Diluted)

$-2.02

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$13M

Stock-Based Comp.

$31M

Balance Sheet

Total Assets

$392M

Total Liabilities

$235M

Stockholders' Equity

$156M

Cash & Equivalents

$191M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$194M	$83M	+135.0%
Gross Profit	$190M	-$35M	+643.4%
Operating Income	-$64M	-$132M	+51.3%
Net Income	-$79M	-$142M	+44.4%